Yibo Zuo

1.0k total citations
32 papers, 722 citations indexed

About

Yibo Zuo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yibo Zuo has authored 32 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Yibo Zuo's work include interferon and immune responses (14 papers), Ubiquitin and proteasome pathways (12 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Yibo Zuo is often cited by papers focused on interferon and immune responses (14 papers), Ubiquitin and proteasome pathways (12 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Yibo Zuo collaborates with scholars based in China, Canada and South Korea. Yibo Zuo's co-authors include Yukang Yuan, Hui Zheng, Liting Zhang, Ying Miao, Qian Feng, Liping Qian, Jin Liu, Tingting Guo, Xiangjie Chen and Qiao Cheng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Genes & Development.

In The Last Decade

Yibo Zuo

30 papers receiving 718 citations

Peers

Yibo Zuo

IMMUN

ONCOL

EPIDE

Marianna Nicoletta Rossi Italy

Yaoji Liang China

Gillian M. Tannahill United Kingdom

Hilary Sandig United Kingdom

Dapei Li China

Idit Kosti United States

Mitsuaki Mori Japan

Sahil Mahajan India

Tatiana B. Kolesnik Australia

Marianna Nicoletta Rossi Italy

Yibo Zuo

560 ×1.3

216 ×0.7

IMMUN

258 ×1.4

ONCOL

160 ×1.3

48 ×0.5

EPIDE

Citations per year, relative to Yibo Zuo Yibo Zuo (= 1×) peers Marianna Nicoletta Rossi

Countries citing papers authored by Yibo Zuo

Since Specialization

Citations

This map shows the geographic impact of Yibo Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibo Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibo Zuo more than expected).

Fields of papers citing papers by Yibo Zuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibo Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibo Zuo. The network helps show where Yibo Zuo may publish in the future.

Co-authorship network of co-authors of Yibo Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Yibo Zuo. A scholar is included among the top collaborators of Yibo Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibo Zuo. Yibo Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Xinyu, Panpan Hao, Yan Chen, et al.. (2025). Ubiquitin-specific protease 21 aggravates enterovirus 71 (EV71) infection by restricting Lys48-linked ubiquitination of EV71-2A protease. International Journal of Biological Macromolecules. 314. 144202–144202.

Chen, Xiangjie, Jin Liu, Yichang Chen, et al.. (2025). Bilirubin metabolism in the liver orchestrates antiviral innate immunity in the body. Cell Reports. 44(4). 115481–115481. 1 indexed citations

Zuo, Yibo, Qin Wang, Qian Zhao, et al.. (2025). β-hydroxybutyrylation and O-GlcNAc modifications of STAT1 modulate antiviral defense in aging. Cellular and Molecular Immunology. 22(4). 403–417. 5 indexed citations

Miao, Ying, Qian Zhao, Wei He, et al.. (2024). DDX4 enhances antiviral activity of type I interferon by disrupting interaction of USP7/SOCS1 and promoting degradation of SOCS1. mBio. 15(3). e0321323–e0321323. 5 indexed citations

Qian, Guanghui, Yukang Yuan, Yibo Zuo, et al.. (2023). Linear ubiquitination improves NFAT1 protein stability and facilitates NFAT1 signalling in Kawasaki disease. FEBS Journal. 290(17). 4224–4237. 1 indexed citations

Yang, Xinyu, Yan Chen, Fan Huang, et al.. (2023). Ubiquitin E3 ligase SPOP is a host negative regulator of enterovirus 71-encoded 2A protease. Journal of Virology. 97(10). e0078623–e0078623. 6 indexed citations

Zuo, Yibo, Ying Miao, Yukang Yuan, et al.. (2023). Vitamin C promotes ACE2 degradation and protects against SARS‐CoV‐2 infection. EMBO Reports. 24(4). e56374–e56374. 12 indexed citations

Chen, Xiangjie, Qian Du, Yukang Yuan, et al.. (2022). Methotrexate and Triptolide regulate Notch signaling pathway by targeting the Nedd4-Numb axis. International Immunopharmacology. 114. 109595–109595. 7 indexed citations

Zhang, Hongguang, Bin Wang, Yang Yong, et al.. (2022). Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis. Cell Research. 32(10). 897–913. 36 indexed citations

10.

Zhang, Liting, Fan Huang, Jin Liu, et al.. (2021). HSV-1-encoded ICP0 degrades the host deubiquitinase BRCC36 to antagonize interferon antiviral response. Molecular Immunology. 135. 28–35. 12 indexed citations

11.

Yuan, Yukang, Fan Huang, Liping Qian, et al.. (2021). High salt activates p97 to reduce host antiviral immunity by restricting Viperin induction. EMBO Reports. 23(1). e53466–e53466. 10 indexed citations

12.

Zuo, Yibo, Qian Feng, Fan Huang, et al.. (2020). Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. Nature Communications. 11(1). 1146–1146. 84 indexed citations

13.

Guo, Tingting, Yibo Zuo, Liping Qian, et al.. (2019). ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP. Nature Microbiology. 4(11). 1872–1884. 66 indexed citations

14.

Qian, Liping, Yibo Zuo, Wenjun Deng, et al.. (2018). MCPIP1 is a positive regulator of type I interferons antiviral activity. Biochemical and Biophysical Research Communications. 498(4). 891–897. 9 indexed citations

15.

Zhang, Liting, Jin Liu, Liping Qian, et al.. (2018). Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome. PLoS Pathogens. 14(5). e1007067–e1007067. 86 indexed citations

16.

Wang, Xiaofang, Liting Zhang, Yunli Zhang, et al.. (2017). JOSD1 Negatively Regulates Type-I Interferon Antiviral Activity by Deubiquitinating and Stabilizing SOCS1. Viral Immunology. 30(5). 342–349. 17 indexed citations

17.

Cheng, Qiao, Yukang Yuan, Lemin Li, et al.. (2017). Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis. Experimental Cell Research. 356(1). 1–7. 5 indexed citations

18.

Zhao, Peng, Tingting Guo, Liping Qian, et al.. (2017). Ubiquitin C-terminal hydrolase-L3 promotes interferon antiviral activity by stabilizing type I-interferon receptor. Antiviral Research. 144. 120–129. 17 indexed citations

19.

Qian, Guanghui, Ying Ren, Yibo Zuo, et al.. (2016). Smurf1 represses TNF-α production through ubiquitination and destabilization of USP5. Biochemical and Biophysical Research Communications. 474(3). 491–496. 14 indexed citations

20.

Ren, Ying, Peng Zhao, Jin Liu, et al.. (2016). Deubiquitinase USP2a Sustains Interferons Antiviral Activity by Restricting Ubiquitination of Activated STAT1 in the Nucleus. PLoS Pathogens. 12(7). e1005764–e1005764. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact